Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Shilpa Gupta MD

Shilpa Gupta MD

Director, Genitourinary Medical Oncology, Taussig Cancer Institute; Co-Leader, Genitourinary Oncology Program, Cleveland Clinic, Cleveland, Ohio

Dr. Shilpa Gupta is the Director of the Genitourinary Medical Oncology at the Taussig Cancer Institute (TCI) in Cleveland, Ohio, and Co-Leader of the Genitourinary Oncology Program at the Cleveland Clinic.

Dr. Gupta obtained her medical degree at the Lady Hardinge Medical College in New Delhi, India, and completed a residency in internal medicine at the University of Connecticut Health Center. She completed her hematology–oncology fellowship at Georgetown University and Thomas Jefferson University, followed by a genitourinary oncology translational research fellowship at Thomas Jefferson University. Prior to joining TCI, she was Associate Professor and Lead for the Solid Tumor Phase 1 Program at the Masonic Cancer Center at the University of Minnesota.

Dr. Gupta is actively involved in research, where her interests focus on novel drug development and understanding biomarkers of response and resistance to therapies in bladder cancer. She has led several investigator-initiated trials in genitourinary cancers and has leadership roles in NCI trials, among others conducted by various clinical trial cooperative groups.

Her research work has been published in peer-reviewed journals, including the Journal of Clinical Oncology, Lancet Oncology, and Clinical Cancer Research. Dr. Gupta is active in several professional organizations, which include the American Society of Clinical Oncology (ASCO), American Urologic Association (AUA), American Association of Cancer Research (AACR), Society of Urologic Oncology (SUO), Society of Immunotherapy for Cancer (SITC), Prostate Cancer Foundation (PCF), and the European society of Medical Oncology (ESMO).